November 11, 2009 (Philadelphia, Pennsylvania) — A subset of patients with solid organ malignancies and pulmonary Mycobacterium avium–complex (MAC) infections might fare worse if the infection is ...

MAC infection is caused by a related group of bacteria, together referred to as the Mycobacterium avium complex (MAC). These bacteria flourish in, for example, water, soil and the bodies of certain ...

DRESHER, PA. (WPVI) -- We need bacteria to digest food and absorb nutrients. However, when a bacteria commonly found in soil and water gets into our lungs, it can cause trouble, in the form of a MAC ...

This section presents medications that are known to potentially lead to 'Mycobacterium avium complex infection' as a side effect. It's important to note that mild side effects are quite common with ...

The U.S. Food and Drug Administration today approved a new drug, Arikayce (amikacin liposome inhalation suspension), for the treatment of lung disease caused by a group of bacteria, Mycobacterium ...

The FDA established the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) as part of the 21st Century Cures Act that was signed into law in December 2016. The LPAD ...

In early 1979, an official of an Illinois hospital reported an increase in the number of patients from whom Mycobacterium avium complex recently had been recovered. Over the preceding 3 years ...

Patients with nontuberculous mycobacterial pulmonary disease caused by Mycobacterium avium complex had significantly improved survival if they achieved microbiological cure at the end of treatment, ...

This is a preview. Log in through your library . Abstract It is difficult to distinguish pulmonary disease due to Mycobacterium avium complex (MAC) from that due to other mycobacteria, such as ...

The CRISPR-based assay works by measuring MAC cell-free DNA (MAC-cfDNA) levels within patient blood samples. The test can yield results in as little as two hours, and the published preliminary ...